woman
cf
homozygot
underw
bilater
sequenti
lung
transplant
year
earlier
develop
new
cough
rhinorrhea
day
cough
worsen
abruptli
develop
fatigu
dyspnea
rest
exert
previou
episod
acut
reject
known
viral
respiratori
tract
ill
sinc
transplant
spirometri
demonstr
forc
vital
capac
fvc
l
predict
forc
expiratori
volum
sec
l
predict
recent
comput
tomographi
ct
chest
demonstr
chronic
chang
clear
lung
field
fig
surgic
histori
nissen
fundopl
symptomat
gastroesophag
reflux
perform
discharg
lung
transplant
complet
resolut
symptom
histori
hla
mismatch
time
transplant
current
immunosuppress
therapi
tacrolimu
mg
twice
daili
mycophenol
mg
twice
daili
prednison
mg
daili
medic
includ
trimethoprimsulfamethoxazol
prophylaxi
pancreat
enzym
supplement
tacrolimu
level
accept
ngml
rang
unabl
perform
spirometri
current
acut
present
nasal
swab
sampl
identifi
rsv
polymeras
chain
reaction
bronchoscopi
perform
reveal
well
heal
anastomos
transbronchi
biopsi
show
giant
cell
fig
consist
rsv
well
sign
acut
allograft
reject
classifi
treat
inhal
ribavirin
daili
intraven
methylprednisolon
g
daili
day
tissu
bronchoalveolar
lavag
fluid
cultur
found
infecti
agent
upper
gastrointestin
studi
along
ph
probe
imped
reveal
evid
gastroesophag
reflux
aspir
blood
neg
cytomegaloviru
viru
spirometri
perform
day
present
reveal
sever
airway
obstruct
fvc
l
predict
l
predict
one
week
initi
present
routin
ct
scan
chest
perform
vagu
chest
pain
show
ground
glass
opac
new
develop
bronchiectasi
fig
repeat
transbronchi
biopsi
week
initi
present
demonstr
complet
resolut
acut
reject
histolog
find
howev
pulmonari
function
improv
eventu
met
diagnost
criteria
bo
sinc
list
understand
pathogenesi
rsv
bo
lung
transplant
remain
limit
conflict
evid
respiratori
virus
report
associ
develop
acut
reject
bo
small
cohort
patient
total
patient
develop
respiratori
viral
ill
specif
viral
etiolog
identifi
includ
rhinoviru
n
coronaviru
n
rsv
n
influenza
n
parainfluenza
n
human
metapneumoviru
n
specif
viral
etiolog
identifi
patient
subsequ
acut
reject
includ
rhinoviru
n
coronaviru
n
rsv
n
influenza
viru
n
moreov
patient
experienc
greater
declin
month
posit
respiratori
viru
rhinoviru
n
coronaviru
n
influenza
n
howev
anoth
studi
investig
report
respiratori
viral
infect
associ
subsequ
graft
dysfunct
smaller
cohort
patient
follow
singl
winter
season
total
patient
symptomat
respiratori
viral
episod
document
infect
includ
rsv
n
influenza
n
parainfluenza
n
recent
hopkin
colleagu
report
cohort
patient
respiratori
viral
infect
signific
percentag
patient
metapneumoviru
rsv
develop
graft
dysfunct
averag
declin
respect
subsequ
bo
onset
progress
occur
patient
human
metapneumoviru
compar
total
patient
rsv
month
patient
bo
reportedli
graft
dysfunct
time
diagnosi
rsv
infect
patient
rsv
initi
recov
baselin
respiratori
function
therapi
subsequ
develop
bo
mean
time
diagnosi
week
case
impress
time
acut
onset
bo
relat
rsv
infect
especi
base
complet
unev
cours
past
year
transplant
think
aggress
bo
support
rapid
chang
ct
imag
fig
b
myriad
abnorm
seen
ct
imag
chest
bo
includ
bronchiectasi
hyperluc
mosaic
pattern
attenu
thicken
septal
line
ct
imag
often
use
complement
pulmonari
function
test
bronchoscopi
help
differenti
caus
dyspnea
declin
pulmonari
function
lung
transplant
recipi
report
jackson
et
al
bo
singl
process
acut
bo
defin
sharp
steep
irrevers
declin
trigger
acut
event
associ
episod
acut
allograft
reject
first
month
poor
prognosi
chronic
form
disord
smooth
linear
declin
pulmonari
function
less
like
associ
acut
event
better
prognosi
case
illustr
differ
phenotyp
bo
exist
fact
acut
chronic
phenotyp
occur
time
lung
transplant
aggress
disord
even
impress
patient
present
herein
compar
case
report
prospect
studi
hopkin
et
al
addit
research
need
identifi
pathogenesi
rsv
infect
relat
develop
bo
lung
transplant
recipi
help
identifi
therapeut
target
optim
outcom
lung
transplant
